Matinas BioPharma Board Approves 1-For-15 Reverse Stock Split Effective September 28, 2026
On June 23, 2025, at the 2025 annual meeting of stockholders of Matinas BioPharma Holdings, Inc. (the "Company"), the stockholders approved the authorization of the Board of Directors (the "Board"), in its sole and absolute discretion and without further stockholder approval, to effect up to two reverse stock splits of the Company’s common stock, par value $0.0001 per share (the "Common Stock"), having an aggregate ratio to be determined by the Board ranging from a ratio of one-for-two (1:2) to a ratio of one-for-one hundred ninety-nine (1:199). Pursuant to the NYSE American’s Compliance Guidance Memo, which requires ten calendar days’ public notice for certain corporate actions, on September 16, 2026, the Company announced that the Board has approved a reverse stock split of the Common Stock at a ratio of one-for-fifteen (1:15) (the "Reverse Stock Split"). The Reverse Stock Split will become effective at 12:01 a.m. Eastern Time on September 28, 2026 (the "Effective Date"), and the shares of Common Stock are expected to begin trading on the split-adjusted basis under the Company’s existing trading symbol, "MTNB," when the market opens on September 28, 2026. The new CUSIP number fol
On June 23, 2025, at the 2025 annual meeting of stockholders of Matinas BioPharma Holdings, Inc. 0001 per share (the "Common Stock"), having an aggregate ratio to be determined by the Board ranging from a ratio of one-for-two (1:2) to a ratio of one-for-one hundred ninety-nine (1:199). Pursuant to the NYSE American’s Compliance Guidance Memo, which requires ten calendar days’ public notice for certain corporate actions, on September 16, 2026, the Company announced that the Board has approved a reverse stock split of the Common Stock at a ratio of one-for-fifteen (1:15) (the "Reverse Stock Split"). m.
Eastern Time on September 28, 2026 (the "Effective Date"), and the shares of Common Stock are expected to begin trading on the split-adjusted basis under the Company’s existing trading symbol, "MTNB," when the market opens on September 28, 2026. The new CUSIP number following the Reverse Stock Split will be 576810 402. On the Effective Date, the total number of shares of Common Stock held by each stockholder of the Company will be converted automatically into the number of shares of Common Stock equal to (i) the number of issued and outstanding shares of Common Stock held by each such stockholder immediately prior to the Reverse Stock Split, divided by (ii) fifteen (15).
No fractional shares will be issued in connection with the Reverse Stock Split. Stockholders who would otherwise be entitled to a fractional share of Common Stock are instead entitled to receive a proportional cash payment.